Sign In
Buy CDLX
$0.650
-0.0015 (-0.230%)
At Close: Jun 03, 2026
Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Cardlytics, Inc. For Securities Law Violations
12:15pm, Friday, 17'th Jan 2025
LOS ANGELES, CA / ACCESS Newswire / January 17, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytic
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm
03:27am, Friday, 17'th Jan 2025
LOS ANGELES , Jan. 17, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc.
CDLX Investor News: Rosen Law Firm Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLX
07:59pm, Thursday, 16'th Jan 2025
NEW YORK , Jan. 16, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cardlytics, Inc
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cardlytics, Inc. (“Card
Cardlytics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders With Losses To Reach Out
11:15am, Thursday, 16'th Jan 2025
LOS ANGELES, CA / ACCESS Newswire / January 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytic
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) on behalf of investors concerning t
Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Cardlytics Inc For Securities Law Violations
12:30pm, Wednesday, 15'th Jan 2025
LOS ANGELES, CA / ACCESSWIRE / January 15, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, In
Cardlytics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders With Losses To Reach Out
08:00pm, Tuesday, 14'th Jan 2025
LOS ANGELES, CA / ACCESSWIRE / January 14, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, In
Cardlytics, Inc. (CDLX) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
07:24pm, Tuesday, 14'th Jan 2025
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) investors concerning the
Cardlytics, Inc. Company Investigated by the Portnoy Law Firm
06:47pm, Tuesday, 14'th Jan 2025
Investors can contact the law firm at no cost to learn more about recovering their losses Investors can contact the law firm at no cost to learn more about recovering their losses
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm
02:39pm, Tuesday, 14'th Jan 2025
LOS ANGELES--(BUSINESS WIRE)--CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm.
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cardlytics, Inc. (NASDAQ: CDLX
Here Is Why Bargain Hunters Would Love Fast-paced Mover Cardlytics (CDLX)
09:51am, Tuesday, 17'th Dec 2024
Cardlytics (CDLX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still tra
Cardlytics, Inc. (CDLX) Q3 2024 Earnings Call Transcript
08:52pm, Wednesday, 06'th Nov 2024
Cardlytics, Inc. (CDLX) Q3 2024 Earnings Call Transcript
Cardlytics (CDLX) Reports Q3 Loss, Tops Revenue Estimates
06:21pm, Wednesday, 06'th Nov 2024
Cardlytics (CDLX) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to earnings of $0.01 per share a year ago.
